UK markets close in 5 hours 36 minutes

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.73-0.29 (-4.13%)
At close: 04:00PM EDT
6.71 -0.02 (-0.30%)
Pre-market: 05:43AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
91,978
86,951
64,872
49,647
16,099
Cost of revenue
19,619
18,838
15,975
6,335
2,738
Gross profit
72,359
68,113
48,897
43,312
13,362
Operating expenses
Research development
6,005
7,086
10,432
19,792
27,299
Selling general and administrative
186,737
200,797
192,964
174,113
115,989
Total operating expenses
192,742
207,883
204,438
194,518
143,582
Operating income or loss
-120,383
-139,770
-155,541
-151,205
-130,220
Interest expense
16,563
22,568
28,581
17,382
4,678
Total other income/expenses net
135,015
272
597.647
-7,558
2,281
Income before tax
-26,570
-172,415
-183,524
-176,145
-132,617
Income tax expense
550
0
0
0
0
Income from continuing operations
-27,120
-172,415
-183,524
-176,145
-132,617
Net income
-27,120
-172,415
-183,524
-176,145
-132,617
Net income available to common shareholders
-27,120
-172,415
-183,524
-176,145
-132,617
Basic EPS
-
-21.50
-33.50
-36.00
-29.50
Diluted EPS
-
-21.50
-33.50
-36.00
-29.50
Basic average shares
-
7,960
5,513
4,927
4,501
Diluted average shares
-
7,960
5,513
4,927
4,501
EBITDA
-
-145,754
-150,877
-157,371
-127,645